Literature DB >> 33569565

Amnestic Mild Cognitive Impairment is Characterized by the Inability to Recover from Proactive Semantic Interference across Multiple Learning Trials.

D A Loewenstein1, R E Curiel Cid, M Kitaigorodsky, E A Crocco, D D Zheng, K L Gorman.   

Abstract

BACKGROUND: Difficulties in inhibition and self-monitoring are early features of incipient Alzheimer's disease and may manifest as susceptibility to proactive semantic interference. However, due to limitations of traditional memory assessment paradigms, recovery from interference effects following repeated learning opportunities has not been explored.
OBJECTIVE: This study employed a novel computerized list learning test consisting of repeated learning trials to assess recovery from proactive and retroactive semantic interference.
DESIGN: The design was cross-sectional.
SETTING: Participants were recruited from the community as part of a longitudinal study on normal and abnormal aging. PARTICIPANTS: The sample consisted of 46 cognitively normal individuals and 30 participants with amnestic mild cognitive impairment. MEASUREMENTS: Participants were administered the Cognitive Stress Test and traditional neuropsychological measures. Step-wise logistic regression was applied to determine which Cognitive Stress Test measures best discriminated between diagnostic groups. This was followed by receiver operating characteristic analyses.
RESULTS: Cued A3 recall, Cued B3 recall and Cued B2 intrusions were all independent predictors of diagnostic status. The overall predictive utility of the model yielded 75.9% sensitivity, 91.1% specificity, and an overall correct classification rate of 85.1%. When these variables were jointly entered into receiver operating characteristic analyses, the area under the curve was .923 (p<.001).
CONCLUSIONS: This novel paradigm's use of repeated learning trials offers a unique opportunity to assess recovery from proactive and retroactive semantic interference. Participants with mild cognitive impairment exhibited a continued failure to recover from proactive interference that could not be explained by mere learning deficits.

Entities:  

Keywords:  Proactive semantic interference; intrusions; mild cognitive impairment; prodromal Alzheimer’s disease; retroactive semantic interference

Mesh:

Year:  2021        PMID: 33569565      PMCID: PMC8500547          DOI: 10.14283/jpad.2021.3

Source DB:  PubMed          Journal:  J Prev Alzheimers Dis        ISSN: 2274-5807


  23 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  Insights into spared memory capacity in amnestic MCI and Alzheimer's Disease via minimal interference.

Authors:  Michaela Dewar; Martina Pesallaccia; Nelson Cowan; Leandro Provinciali; Sergio Della Sala
Journal:  Brain Cogn       Date:  2012-01-17       Impact factor: 2.310

3.  Recovery from Proactive Semantic Interference and MRI Volume: A Replication and Extension Study.

Authors:  David A Loewenstein; Rosie E Curiel; Steven DeKosky; Monica Rosselli; Russell Bauer; Maria Grieg-Custo; Ailyn Penate; Chunfei Li; Gabriel Lizagarra; Todd Golde; Malek Adjouadi; Ranjan Duara
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

4.  Comparison between FCSRT and LASSI-L to Detect Early Stage Alzheimer's Disease.

Authors:  Jordi A Matias-Guiu; María Nieves Cabrera-Martín; Rosie E Curiel; María Valles-Salgado; Teresa Rognoni; Teresa Moreno-Ramos; José Luis Carreras; David A Loewenstein; Jorge Matías-Guiu
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

5.  Types of errors on a semantic interference task in mild cognitive impairment and dementia.

Authors:  Valeria L Torres; Mónica Rosselli; David A Loewenstein; Rosie E Curiel; Idaly Vélez Uribe; Merike Lang; Fernanda Arruda; Ailyn Penate; David E Vaillancourt; Maria T Greig; William W Barker; Russell M Bauer; Ranjan Duara
Journal:  Neuropsychology       Date:  2019-05-09       Impact factor: 3.295

6.  Utilizing semantic intrusions to identify amyloid positivity in mild cognitive impairment.

Authors:  David A Loewenstein; Rosie E Curiel; Steven DeKosky; Russell M Bauer; Monica Rosselli; Salvador M Guinjoan; Malek Adjouadi; Ailyn Peñate; William W Barker; Sindy Goenaga; Todd Golde; Maria T Greig-Custo; Kevin S Hanson; Chunfei Li; Gabriel Lizarraga; Michael Marsiske; Ranjan Duara
Journal:  Neurology       Date:  2018-08-03       Impact factor: 9.910

7.  Proactive and retroactive interference in young adults, healthy older adults, and older adults with amnestic mild cognitive impairment.

Authors:  Patricia L Ebert; Nicole D Anderson
Journal:  J Int Neuropsychol Soc       Date:  2009-01       Impact factor: 2.892

8.  Task switching capacities in persons with Alzheimer's disease and mild cognitive impairment.

Authors:  Sylvie Belleville; Louis Bherer; Emilie Lepage; Howard Chertkow; Serge Gauthier
Journal:  Neuropsychologia       Date:  2008-02-17       Impact factor: 3.139

9.  Failure to Recover from Proactive Semantic Interference and Abnormal Limbic Connectivity in Asymptomatic, Middle-Aged Offspring of Patients with Late-Onset Alzheimer's Disease.

Authors:  Stella M Sánchez; Carolina Abulafia; Barbara Duarte-Abritta; M Soledad Ladrón de Guevara; Mariana N Castro; Lucas Drucaroff; Gustavo Sevlever; Charles B Nemeroff; Daniel E Vigo; David A Loewenstein; Mirta F Villarreal; Salvador M Guinjoan
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

10.  Interference Impacts Working Memory in Mild Cognitive Impairment.

Authors:  Sara Aurtenetxe; Javier García-Pacios; David Del Río; María E López; José A Pineda-Pardo; Alberto Marcos; Maria L Delgado Losada; José M López-Frutos; Fernando Maestú
Journal:  Front Neurosci       Date:  2016-10-13       Impact factor: 4.677

View more
  1 in total

Review 1.  Salient Cognitive Paradigms to Assess Preclinical Alzheimer's Disease.

Authors:  Rosie E Curiel Cid; David A Loewenstein
Journal:  Neurotherapeutics       Date:  2022-03-04       Impact factor: 6.088

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.